SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Immunosyn Corp – ‘SB-2/A’ on 11/3/06

On:  Friday, 11/3/06, at 2:27pm ET   ·   Accession #:  950123-6-13469   ·   File #:  333-137881

Previous ‘SB-2’:  ‘SB-2’ on 10/6/06   ·   Next & Latest:  ‘SB-2/A’ on 12/22/06

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/03/06  Immunosyn Corp                    SB-2/A                 1:18K                                    RR Donnelley/FA

Pre-Effective Amendment to Registration of Securities by a Small-Business Issuer   —   Form SB-2
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SB-2/A      Amendment No. 1 to Form SB-2                        HTML     20K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Table of Contents
"Explanatory Note
"Signatures

This is an HTML Document rendered as filed.  [ Alternative Formats ]



  SB-2/A  

Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
Pre-Effective Amendment No. 1
to
FORM SB-2
 
REGISTRATION STATEMENT
UNDER THE
SECURITIES ACT OF 1933
IMMUNOSYN CORPORATION
(Name of Small Business Issuer in Its Charter)
         
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
  2836
(Primary Standard Industrial
Classification Code Number)
  20-5322896
(I.R.S. Employer Identification
Number)
4225 Executive Square, Suite 260
La Jolla, California 92037
(858) 200-2320
(Address and Telephone Number of Principal Executive Offices)
4225 Executive Square, Suite 260
La Jolla, California 92037
(858) 200-2320
(Address of Principal Place of Business or Intended Principal Place of Business)
Douglas McClain, Jr.
4225 Executive Square, Suite 260
La Jolla, California 92037
(858) 200-2320
(Name, Address and Telephone Number of Agent for Service)
Approximate Date of Commencement of Proposed Sale to the Public: As soon as practicable after this registration statement becomes effective.
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o ______________________________
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o ______________________________
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o ______________________________
If delivery of the prospectus is expected to be made pursuant to Rule 434, check the following box. o
CALCULATION OF REGISTRATION FEE
                                             
 
Title of each class of
Securities to be
Registered
    Amount to be
registered
    Proposed Maximum
Offering Price Per
Share (1)
    Proposed Maximum
Aggregate Offering
Price
    Amount of
Registration Fee
 
 
Common Stock, par value $0.0001 per share
      272,000,000       $ .05       $ 13,600,000       $ 1,455.20 (2)  
 
(1)   Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended.
 
(2)   Previously paid.
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
 
 


TABLE OF CONTENTS

EXPLANATORY NOTE
SIGNATURES


Table of Contents

EXPLANATORY NOTE
     This Pre-Effective Amendment No. 1 to the Registration Statement on Form SB-2 of Immunosyn Corporation is being filed solely for the inclusion of the signature of its chief accounting officer.

2



Table of Contents

SIGNATURES
     In accordance with the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements of filing on Form SB-2 and authorized this pre-effective amendment no. 1 to the registration statement to be signed on its behalf by the undersigned, in the City of La Jolla, State of California on November 2, 2006.
         
  IMMUNOSYN CORPORATION
 
 
  By:   /s/ Douglas McClain, Jr.    
    Chief Financial and Accounting Officer   
       
 
     In accordance with the requirements of the Securities Act of 1933, this pre-effective amendment no. 1 to the registration statement was signed by the following persons in the capacities and on the dates stated:
         
Signature
  Title   Date
 
       
  President, Chief Executive
Officer, Director
  November 2, 2006
 
       
  Chief Financial and Accounting Officer, Director   November 2, 2006

3


Dates Referenced Herein

This ‘SB-2/A’ Filing    Date    Other Filings
Filed on:11/3/06None on these Dates
11/2/06
 List all Filings 
Top
Filing Submission 0000950123-06-013469   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 5:16:55.2pm ET